Unternehmen / Aktien | News 24 h |
News 7 T |
Kurs | ||
---|---|---|---|---|---|
ASTRAZENECA | 40 | 108 | +0,29 % | ||
ABB | 2 | 7 | -0,30 % | ||
NORDEA BANK | 2 | 5 | +2,70 % | ||
H&M | 2 | 4 | -0,86 % | ||
SWEDBANK | 2 | 2 | -0,11 % | ||
ERICSSON | 1 | 6 | +1,80 % | ||
SKANSKA | 1 | 3 | +2,08 % | ||
ALFA LAVAL | 1 | 3 | +0,37 % | ||
SEB AB A | 1 | 2 | +0,73 % | ||
KINNEVIK | - | 8 | 0,00 % |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN
|
Leser | Medien | ||
---|---|---|---|---|---|
03:05 | Hitachi ABB Power Grids Joins Effort to Protect Power Utilities from Cyber Threats | 215 | JCN Newswire | Global leader and pioneer in power technologies will share cybersecurity information with utilities through the Fortress' Asset to Vendor NetworkWashington, Aug 26, 2020 - (JCN Newswire) - Hitachi ABB... ► Artikel lesen |
|
00:22 | AstraZeneca Starts Clinical Trial Testing Its COVID-19 Treatment Antibody Cocktail | 1 | The Motley Fool | ||
Di | Technavio Research: Analysis on Impact of COVID-19- Global Clostridium Difficile Treatment Market 2020-2024 | Evolving Opportunities With Astellas Pharma Inc. and AstraZeneca Plc | Technavio | 739 | Business Wire | The global clostridium difficile treatment market size is expected to grow by USD 159.87 million as per Technavio. This marks a significant market growth compared to the 2019 growth estimates due... ► Artikel lesen |
|
Di | AstraZeneca is not involved in talks over emergency COVID-19 vaccine use: spokeswoman | 8 | FiercePharma | ||
Di | UK study to assess AstraZeneca drug in diabetic COVID-19 patients | 3 | Seeking Alpha | ||
Di | Last Call! - Der Marktbericht am Abend: Mit Fraport, Siltronic, Medtronic, AstraZeneca und Tesla | 1.702 | Börse Global | Guten Abend, die Aufregung um das Thema "Impfstoff" herum sorgt auch heute für etwas Optimismus auf dem Parkett. Da interessieren auch keine aktuellen "Fallzahlen" mehr. Zudem schaut ohnehin keiner... ► Artikel lesen |
|
Di | AstraZeneca: Impfstoffforschung weit fortgeschritten - Zulassungsantrag könnte noch 2020 erfolgen | 17 | OnVista | ||
Di | AstraZeneca-Aktie schwächer: Zulassungsantrag für Corona-Impfstoff vielleicht noch 2020 - Studie für Antikörper-Behandlung gestartet | 212 | finanzen.net | Der britische Pharmakonzern AstraZeneca kommt bei der Entwicklung eines COVID-19-Medikaments voran. Wie das Unternehmen mitteilte, hat eine klinische Phase-1-Studie des Wirkstoffs mit der Bezeichnung... ► Artikel lesen |
|
Di | AstraZeneca Begins Human Trials of COVID-19 Antibody Treatment | 2 | GMP news | ||
Di | AstraZeneca Coronavirus Treatment Testing Begins; 'Important Milestone' | 2 | Investor's Business Daily | ||
Di | Troy Wilson recruits AstraZeneca vet to steer Kura's late-stage pivot | 2 | Endpoints News | ||
Di | H&M LAB Deutschland launcht erste Kampagne für Wearable Tech Kollektion | - | FashionNetwork.com | ||
Di | Swedbank Economic Outlook: Baltic - resilient and likely to recover swiftly | - | Baltic Course | ||
Di | H&M collaborates with Giuliva Heritage | 1 | The Retail Bulletin | ||
Di | WATCH | AstraZeneca starts trials of virus treatment | 5 | fin24.co.za | ||
Di | AstraZeneca Kicks Off Covid-19 Antibody Trials | 4 | The Street | ||
Di | AstraZeneca Coronavirus Vaccine May Get FDA's Emergency Tag | 5 | Zacks | ||
Di | AstraZeneca starts phase 1 of antibodies that could protect against COVID-19 for 6 months | 7 | FierceBiotech | ||
Di | ASTRAZENECA PLC - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
Di | Swedbank reduces Latvia's GDP reduction forecast for 2020 to 5% | 1 | Baltic Course |